First real-world evidence of sparsentan efficacy in patients with IgA nephropathy treated with SGLT2 inhibitors

DSpace Repository

First real-world evidence of sparsentan efficacy in patients with IgA nephropathy treated with SGLT2 inhibitors

Author: Schanz, Moritz; Seikrit, Claudia; Hohenstein, Bernd; Zimmermann, Aline; Kraft, Leonie; Schricker, Severin; Berger, Susann; Schwab, Andrea; Oberacker, Tina; Latus, Joerg
Tübinger Autor(en):
Oberacker, Tina
Published in: Clinical Kidney Journal (2025), Bd. 18, H. 1
Verlagsangabe: Oxford : Oxford Univ Press
Language: English
Full text: http://dx.doi.org/10.1093/ckj/sfae394
ISSN: 2048-8505
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)